NGVT

Ingevity Corp Materials Chemicals & Allied Products Russell 3000
$74.32Close $2.6BMarket cap $46.20 – $77.8752-week range Nov 4, 2026Next report · after the close

Highlights

Strengths

  • Near its high 5% below its 52-week high

Cautions

  • Trend not confirmed 6 of 8 conditions · 50-day under the 150/200-day, RS under 70
  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Jul 30, 2026
Off 12-month high 5%
1wk up 6.7% price change
1mo up 5.0% price change
12-month return up 39% market up 11% · its own up 27%
F-score 6 / 9 Mixed
Altman Z 2.95 Moderate risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 88.8× price / book
Earnings yield up 11.1% EBIT / enterprise value
Cheaper than 61% of the market · cheap
Revenue growth down 3% year on year
EPS growth — latest quarter
Sales growth down 5% latest quarter · -9 pts
ROE down 149% return on equity
Free cash margin up 23% $273.5M FCF
D/E 40.69 long-term debt / equity
Net debt / EBITDA 2.2×
Interest cover 5.3×EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • took on more long-term debt
  • short-term liquidity weakened
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • no new shares issued
  • gross margin widened
  • assets working harder

Repair signals

  • Long-term debt down 14% ($1.4B → $1.2B)

Trade setup

ATR% 2.8% $2.10 a day · 2×ATR $70.11
RS 63 / 99 vs the universe
Trend 6 / 8 50-day under the 150/200-day, RS under 70
Relative volume 1.1× vs 50-day average
Up/down volume 1.38 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 6 of 8
  • 50-day average above the 150 and 200-day: fails
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Revenue shrinking Revenue fell 2.7% over the year, from $1.2B to $1.2B.
Last reported Jul 29, 2026

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $1.2B -3% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.2B FY2021 · $1.4B FY2022 · $1.7B FY2023 · $1.2B FY2024 · $1.2B FY2025 · $1.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$167.1M
-$500M $0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $181.4M FY2021 · $118.1M FY2022 · $211.6M FY2023 · -$5.4M FY2024 · -$430.3M FY2025 · -$167.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $273.5M +436% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $270.3M FY2021 · $189.5M FY2022 · $170.9M FY2023 · $95.3M FY2024 · $51.0M FY2025 · $273.5M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 40%
  • Net -14%
  • Free cash 23%
-50% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 38% · Net 15% · Free cash 22% FY2021 · Gross 37% · Net 8% · Free cash 14% FY2022 · Gross 34% · Net 13% · Free cash 10% FY2023 · Gross 37% · Net -0% · Free cash 8% FY2024 · Gross 39% · Net -36% · Free cash 4% FY2025 · Gross 40% · Net -14% · Free cash 23%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.1B net debt
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $257.7M · Long-term debt $1.3B FY2021 · Cash $275.4M · Long-term debt $1.3B FY2022 · Cash $76.7M · Long-term debt $1.5B FY2023 · Cash $95.9M · Long-term debt $1.5B FY2024 · Cash $68.0M · Long-term debt $1.4B FY2025 · Cash $78.1M · Long-term debt $1.2B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 35.49m -12.4% since FY2020
40.51m 35.49m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 40.51m FY2021 · 39.27m FY2022 · 37.30m FY2023 · 36.23m FY2024 · 36.35m FY2025 · 35.49m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.2B $1.4B $1.7B $1.2B $1.2B $1.2B
Gross margin 38% 37% 34% 37% 39% 40%
Operating income $397.9M $422.2M $452.6M $423.2M $425.9M $418.7M
Net income $181.4M $118.1M $211.6M -$5.4M -$430.3M -$167.1M
Net margin 15% 8% 13% -0% -36% -14%
Earnings per share $4.37 $2.95 $5.50 -$0.15 -$11.85 -$4.61
Free cash flow $270.3M $189.5M $170.9M $95.3M $51.0M $273.5M
Free cash margin 22% 14% 10% 8% 4% 23%
Cash $257.7M $275.4M $76.7M $95.9M $68.0M $78.1M
Long-term debt $1.3B $1.3B $1.5B $1.5B $1.4B $1.2B
Shareholders' equity $642.1M $673.8M $698.3M $631.4M $195.2M $29.7M
Shares outstanding 40.51m 39.27m 37.30m 36.23m 36.35m 35.49m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Jul 30, 2026 Quarterly ↗ Jun 30, 2026 30d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 6, 2025 Quarterly ↗ Mar 31, 2025 36d
Feb 19, 2025 Annual ↗ Dec 31, 2024 50d
Oct 30, 2024 Quarterly ↗ Sep 30, 2024 30d
Aug 1, 2024 Quarterly ↗ Jun 30, 2024 32d
May 2, 2024 Quarterly ↗ Mar 31, 2024 32d
Feb 22, 2024 Annual ↗ Dec 31, 2023 53d
Nov 2, 2023 Quarterly ↗ Sep 30, 2023 33d

Current reports